Antimicrobial resistance monitoring in commensal enterococci from healthy cattle, pigs and chickens across Europe during 2004–14 (EASSA Study)

There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

Abstract

The European Antimicrobial Susceptibility Surveillance in Animals (EASSA) programme collects zoonotic and commensal bacteria from healthy food-producing animals at slaughter and tracks their susceptibility to medically important antibiotics. Results for enterococci, collected over three time periods, are presented.

Related collections

Most cited references 26

Record: found
Abstract: found
Article: not found

A novel gene, optrA, that confers transferable resistance to oxazolidinones and phenicols and its presence in Enterococcus faecalis and Enterococcus faecium of human and animal origin.

Yang Wang, Yuan Lv, Jiachang Cai … (2015)

The oxazolidinone-resistant Enterococcus faecalis E349 from a human patient tested negative for the cfr gene and 23S rRNA mutations. Here we report the identification of a novel oxazolidinone resistance gene, optrA, and a first investigation of the extent to which this gene was present in E. faecalis and Enterococcus faecium from humans and food-producing animals.

0 comments Cited 206 times – based on 0 reviews      Review now

Bookmark

Record: found
Abstract: found
Article: not found

Vancomycin-resistant enterococci.

Y Çetinkaya, P Falk, C. G. Mayhall (2000)

After they were first identified in the mid-1980s, vancomycin-resistant enterococci (VRE) spread rapidly and became a major problem in many institutions both in Europe and the United States. Since VRE have intrinsic resistance to most of the commonly used antibiotics and the ability to acquire resistance to most of the current available antibiotics, either by mutation or by receipt of foreign genetic material, they have a selective advantage over other microorganisms in the intestinal flora and pose a major therapeutic challenge. The possibility of transfer of vancomycin resistance genes to other gram-positive organisms raises significant concerns about the emergence of vancomycin-resistant Staphylococcus aureus. We review VRE, including their history, mechanisms of resistance, epidemiology, control measures, and treatment.

0 comments Cited 195 times – based on 0 reviews      Review now

Bookmark

Record: found
Abstract: found
Article: not found

EUCAST expert rules in antimicrobial susceptibility testing.

R Leclercq, R Canton, D.F.J. Brown … (2013)

EUCAST expert rules have been developed to assist clinical microbiologists and describe actions to be taken in response to specific antimicrobial susceptibility test results. They include recommendations on reporting, such as inferring susceptibility to other agents from results with one, suppression of results that may be inappropriate, and editing of results from susceptible to intermediate or resistant or from intermediate to resistant on the basis of an inferred resistance mechanism. They are based on current clinical and/or microbiological evidence. EUCAST expert rules also include intrinsic resistance phenotypes and exceptional resistance phenotypes, which have not yet been reported or are very rare. The applicability of EUCAST expert rules depends on the MIC breakpoints used to define the rules. Setting appropriate clinical breakpoints, based on treating patients and not on the detection of resistance mechanisms, may lead to modification of some expert rules in the future. © 2011 The Authors. Clinical Microbiology and Infection © 2011 European Society of Clinical Microbiology and Infectious Diseases.

0 comments Cited 184 times – based on 0 reviews      Review now

Bookmark

All references

Author and article information

Journal

Title: Journal of Antimicrobial Chemotherapy

Publisher: Oxford University Press (OUP)

ISSN (Print): 0305-7453

ISSN (Electronic): 1460-2091

Publication date Created: April 2019

Publication date Created: April 01 2019

Publication date Created: January 08 2019

Publication date Other: April 2019

Publication date (Print): April 01 2019

Publication date (Electronic): January 08 2019

Volume: 74

Issue: 4

Pages: 921-930

Affiliations

[1 ]EASSA Study Group, c/o CEESA, 168, Av de Tervueren, Brussels, Belgium

[2 ]Bayer Animal Health GmbH, Monheim, Germany

[3 ]Elanco Animal Health, Basingstoke, UK

[4 ]MSD Animal Health Innovation GmbH, Schwabenheim, Germany

[5 ]Zoetis, Zaventem, Belgium

[6 ]Vetoquinol S.A., Lure, France

[7 ]Virbac S.A., Carros, France

Article

DOI: 10.1093/jac/dky537

PubMed ID: 30624665

SO-VID: 6914aae7-2ad5-4953-b14a-d247476e423d

License:

https://academic.oup.com/journals/pages/open_access/funder_policies/chorus/standard_publication_model

History

Data availability:

Comments

Comment on this article

scite_

Smart Citations

Citing PublicationsSupportingMentioningContrasting

View Citations

See how this article has been cited at scite.ai

scite shows how a scientific paper has been cited by providing the context of the citation, a classification describing whether it supports, mentions, or contrasts the cited claim, and a label indicating in which section the citation was made.

Antimicrobial resistance monitoring in commensal enterococci from healthy cattle, pigs and chickens across Europe during 2004–14 (EASSA Study)

Read this article at

Abstract

Related collections

ScienceOpen Research

Most cited references 26

A novel gene, optrA, that confers transferable resistance to oxazolidinones and phenicols and its presence in Enterococcus faecalis and Enterococcus faecium of human and animal origin.

Vancomycin-resistant enterococci.

EUCAST expert rules in antimicrobial susceptibility testing.

Author and article information

Journal

Affiliations

Article

History

Comments

Comment on this article

Similar content 3,484

Cited by 21

Most referenced authors 402